Biodel is a specialty pharmaceutical company that is engaged in the development and commercialization of innovative treatments for diabetes that are potentially safer, more effective and more convenient for diabetic patients. The company develops its product candidates by improving the therapeutic profiles of existing drugs through the application of proprietary formulation technologies. For more information, visit the company’s Web site at www.biodel.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: